Evidence map›Paper›PMID 35288977›Full record

ArticleDiabetic medicine : a journal of the British Diabetic Association2022

Undiagnosed diabetes: Prevalence and cardiovascular risk profile in a population-based study of 52,856 individuals. The HUNT Study, Norway.

Vera Vik Bjarkø, Eirin B Haug, Elin P Sørgjerd, Lars C Stene, Paz Lopez-Doriga Ruiz, Kåre I Birkeland, Tore Julsrud Berg, Hanne Løvdal Gulseth, Marjolein M Iversen, Arnulf Langhammer and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Diabetic medicine : a journal of the British Diabetic Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Type 2 diabetes in Norway 2009-2021: Have declining incidence rates continued?Diabetic medicine : a journal of the British Diabetic Association · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Vera Vik BjarkøK.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.ORCID 0000-0002-7769-8780
Eirin B HaugK.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.
Elin P SørgjerdClinic of Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Lars C SteneDepartment of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Paz Lopez-Doriga RuizDepartment of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.ORCID 0000-0002-3404-2060
Kåre I BirkelandInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Tore Julsrud BergInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Hanne Løvdal GulsethDepartment of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Marjolein M IversenFaculty of Health and Social Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
Arnulf LanghammerHUNT Research Centre, Department of Public Health and Nursing, Norwegian University of Science and Technology, Levanger, Norway.
Bjørn Olav ÅsvoldK.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.
Norwegian University of Science and Technology · NONorwegian Institute of Public Health · NOUniversity of Oslo · NOOslo University Hospital · NOWestern Norway University of Applied Sciences · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsWe investigated the current extent of undiagnosed diabetes and prediabetes and their associated cardiovascular risk profile in a population-based study.

methodsAll residents aged ≥20 years in the Nord-Trøndelag region, Norway, were invited to the HUNT4 Survey in 2017-2019, and 54% attended. Diagnosed diabetes was self-reported, and in those reporting no diabetes HbA1c was used to classify undiagnosed diabetes (≥48 mmol/mol [6.5%]) and prediabetes (39-47 mmol/mol [5.7%-6.4%]). We estimated the age- and sex-standardized prevalence of these conditions and their age- and sex-adjusted associations with other cardiovascular risk factors.

resultsAmong 52,856 participants, the prevalence of diabetes was 6.0% (95% CI 5.8, 6.2), of which 11.1% were previously undiagnosed (95% CI 10.1, 12.2). The prevalence of prediabetes was 6.4% (95% CI 6.2, 6.6). Among participants with undiagnosed diabetes, 58% had HbA1c of 48-53 mmol/mol (6.5%-7.0%), and only 14% (i.e., 0.1% of the total study population) had HbA1c >64 mmol/mol (8.0%). Compared with normoglycaemic participants, those with undiagnosed diabetes or prediabetes had higher body mass index, waist circumference, systolic blood pressure, triglycerides and C-reactive protein but lower low-density lipoprotein cholesterol (all p < 0.001). Participants with undiagnosed diabetes had less favourable values for every measured risk factor compared with those with diagnosed diabetes.

conclusionsThe low prevalence of undiagnosed diabetes suggests that the current case-finding-based diagnostic practice is well-functioning. Few participants with undiagnosed diabetes had very high HbA1c levels indicating severe hyperglycaemia. Nonetheless, participants with undiagnosed diabetes had a poorer cardiovascular risk profile compared with participants with known or no diabetes.

Indexed as

Cardiovascular DiseasesDiabetes MellitusPrediabetic StateBlood GlucoseGlycated HemoglobinHeart Disease Risk FactorsHumansPrevalenceRisk FactorsBlood GlucoseGlycated Hemoglobindiabetes mellitusepidemiologyglycated haemoglobin Aheart disease risk factorsprediabetic stateprevalenceundiagnosed diseases

Identifiers

PMID35288977
PMCPMC9310609
OpenAlexW4220875168

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.